STEAP3 is a transmembrane protein that belongs to the STEAP family and is primarily expressed in the prostate, testes, and several other tissues. It plays an important role in transport and signaling across the cell membrane. Due to its expression in certain cancers, such as prostate cancer and breast cancer, STEAP3 is being studied as a potential biomarker and therapeutic target, particularly in the development of targeted therapies and immunotherapies for these cancers.
Genomeditech provides resources related to the STEAP3 target, including overexpression cell lines, which can support the in vitro activity validation of STEAP3-targeting antibodies. These tools will assist researchers in better evaluating and optimizing the development of STEAP3-related drugs, advancing their application in tumor immunotherapy.
